Ligand Pharmaceuticals (LGND) Asset Utilization Ratio (2011 - 2026)

Ligand Pharmaceuticals has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.18 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.18, down 9.67% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.18 (down 9.67% YoY), and the FY2025 annual result was 0.21, up 10.83% from the prior year.
• Asset Utilization Ratio came in at 0.18 for Q1 2026 at Ligand Pharmaceuticals, up from 0.18 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.26 in Q1 2023 to a low of 0.14 in Q1 2024.
• The 5-year median for Asset Utilization Ratio is 0.19 (2022), against an average of 0.19.
• Across the five-year window, Asset Utilization Ratio plunged 46.27% in 2024 and jumped 41.26% in 2025, its largest moves.
• Ligand Pharmaceuticals' Asset Utilization Ratio stood at 0.22 in 2022, then declined by 22.05% to 0.17 in 2023, then climbed by 4.45% to 0.18 in 2024, then gained by 0.16% to 0.18 in 2025, then advanced by 0.55% to 0.18 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.18 (Q1 2026), 0.18 (Q4 2025), and 0.21 (Q3 2025), per Business Quant data.